Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

Surendra Kumar Sahoo was just 27 years old when he discovered that he was suffering from end-stage renal disease, which meant ...

Chronic kidney disease can be a silent killer; thus, we need to know about the causes and symptoms of CKD in advance for ...

Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...

World Kidney Day was observed at GMCH highlighting the escalating prevalence of Chronic Kidney Disease (CKD) in Assam.

Lifestyle changes play a significant role in preventing CKD. Small changes, like reducing salt intake and staying active, can ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

Chronic Kidney Disease (CKD) indicates prolonged kidney damage over three months, often undetectable until significant harm ...

Researchers investigated the potential association between plasma apolipoprotein M (APOM) levels and the risk of adverse ...

People with diabetes and high blood pressure are more susceptible to chronic kidney disease. Know treatment options, ...